Skip to content

Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore

A Randomized, Double-blind, Placebo-controlled Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01351493
Enrollment
40
Registered
2011-05-11
Start date
2012-07-31
Completion date
2013-07-31
Last updated
2012-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcer

Keywords

pressure sore, nitric oxide

Brief summary

The purpose of this study is to evaluate the efficacy of nitric oxide gel for pressure sore recovery.

Detailed description

Pressure sore is a common problem for patient with bed-ridden. The care of pressure sore cost many social and medical resource, and also effect the quality of life of patients. Current principles of treatment of pressure sore include adequate pain control, optimizing nutritional status, pressure relief, wound cleaning and dressing, infection control and surgical intervention if needed. Wound dressings should be based on wound characteristics. However, for improving wound healing, different dressing materials were developed. There are increased evidences implicate nitric oxide (NO) synthesis plays an important role in the process of wound healing. Nitric oxide involve in angiogenesis, mediating inflammatory process, cell proliferation and collagen disposition, then improving wound healing. One study used topic NO-gel to mice with second degree burn wound, and found that the NO gel had the potential to enhance burn wound healing by regulation of many cellular processes in the skin. Based on the findings, the investigators hypothesize that NO gel could be used as an alternative method for pressure sore dressing to enhance wound healing. This is a 12-week study. The investigators plan to enroll 40 subjects. The run-in period is set for screening based on inclusion and exclusion criteria. Baseline data including demographic profiles, medical history and current medications will be obtained, followed by an intact pressure sore inspection. Pressure ulcer stage (developed by NPAUP) , Pressure Ulcer Scale for Healing(PUSH) and Pressure Sore Status Tool(PSST) will be recorded before randomization. Baseline photograph of pressure sore will be taken . During the treatment phase, a NO gel or placebo gel will be administered on the pressure sore wound by caregiver once or twice daily (decided by doctor according to clinical condition) after standard wound cleaning with normal saline. During the treatment period, the study subjects will be followed- up every 2 weeks to record the wound condition and any side effect. The investigators will use stage, PUSH and PSST, and take serial photograph to monitor wound condition.

Interventions

DRUGNitric Oxide

Nitric Oxide Gel, once or twice per day, 12weeks

DRUGplacebo

placebo Gel, once or twice per day, 12weeks

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Subjects who live in nursing home * Clinical diagnosis of pressure sore \> grade II(grade developed by NPAUP) * without acute illness required hospitalization * able to understanding and signed the Inform Consent Form after detailed description of the treatment and potential risks and benefits

Exclusion criteria

* diagnosis of cancer and still on active therapies * on other medications with pharmacological actions may lead to excessive formation of nitric oxide, or may accentuate drug effects due to excessive formation of nitric oxide * with systemic infection and need systemic antibiotics * pressure sore local infection and need topic antibiotic(for pressure sore wound) * with any known allergic reaction to any ingredient in the 2 gel prescriptions * Subjects who have been enrolled into any other clinical study in the preceding 3 months prior to randomization

Design outcomes

Primary

MeasureTime frame
Pressure ulcer stage assessment after the endpoint of intervention period12 weeks

Secondary

MeasureTime frame
The secondary efficacy end point will be pressure sore scale assessment of improvement.12 weeks

Countries

Taiwan

Contacts

Primary ContactChiu-Shong Liu, MD.MSc.
liucs@ms14.hinet.net886-975681842

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026